Search Results - "Marsh, Sydney"

Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers by Marsh, Sydney, Borges, Virginia F., Coons, Helen L., Afghahi, Anosheh

“…Purpose Sexual dissatisfaction after breast cancer treatment is a common phenomenon that, unfortunately, places a significant strain on young women and is…”
Get full text

Anxiety and depression: Easing the burden in COPD patients by Marsh, Sydney, Guck, Thomas P

“…Anxiety and depression are common comorbidities of COPD. The simple evaluation tools and therapy options described here can help improve patients' quality of…”
Get full text

Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies by Goddard, Erica T, Linde, Miles H, Srivastava, Shivani, Klug, Grant, Shabaneh, Tamer B, Iannone, Santino, Grzelak, Candice A, Marsh, Sydney, Riggio, Alessandra I, Shor, Ryann E, Linde, Ian L, Guerrero, Marissa, Veatch, Joshua R, Snyder, Annelise G, Welm, Alana L, Riddell, Stanley R, Ghajar, Cyrus M

“…The period between "successful" treatment of localized breast cancer and the onset of distant metastasis can last many years, representing an unexploited…”
Get more information

Effect of radiotherapy treatment modalities on survival in stage IIa prostate cancer: A National Cancer Data Base (NCDB) analysis by Malouff, Timothy Dean, Marsh, Sydney, Silberstein, Peter T.

“…Abstract only…”
Get full text

Overall survival in stage II prostate cancer after radiation or surgical therapy by Marsh, Sydney, Walters, Ryan W, Silberstein, Peter T.

“…Abstract only…”
Get full text

Impact of location on survival in prostate cancer by Maldonado, Edward, Malouff, Timothy Dean, Marsh, Sydney, Silberstein, Peter T.

“…Abstract only…”
Get full text

Twenty-one-gene recurrence score (RS) in germline (g) CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study by Afghahi, Anosheh, Marsh, Sydney, Winchester, Alyse, Gao, Dexiang, Parris, Hannah, Axell, Lisen, Ellisen, Leif W., Hofstatter, Erin Wysong, Kurian, Allison W., Wood, Marie, Zakalik, Dana, Mullin, Carol-Ann, Caswell-Jin, Jennifer Lee, Borges, Virginia F., Tung, Nadine M.

“…Abstract only 10531 Background: Genomic assays, such as RS, are used to determine chemotherapy benefit in early-stage, estrogen receptor (ER)- and/or…”
Get full text

Impact of income in stage IV prostate cancer by Ahmed, Aabra, Malouff, Timothy Dean, Walters, Ryan W, Marsh, Sydney, Silberstein, Peter T.

“…Abstract only 244 Background: There is growing evidence of the impact of socioeconomic status on survival in cancer patients. To our knowledge, this is the…”
Get full text

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small-Cell Lung Cancer by Patil, Tejas, Mushtaq, Rao, Marsh, Sydney, Azelby, Christine, Pujara, Miheer, Davies, Kurtis D., Aisner, Dara L., Purcell, William T., Schenk, Erin L., Pacheco, Jose M., Bunn, Paul A., Camidge, D. Ross, Doebele, Robert C.

“…The clinicopathologic characteristics, acquired resistance patterns, and outcomes among patients with atypical EGFR mutations and HER2 alterations remain…”
Get full text

Survival Outcomes of Radical Prostatectomy Versus Radiotherapy in Intermediate-Risk Prostate Cancer: A NCDB Study by Marsh, Sydney, Walters, Ryan W., Silberstein, Peter T.

“…We used the National Cancer Data Base to evaluate survival in intermediate-risk prostate cancer. We included 268,378 men for survival and multivariable…”
Get full text

Clinicopathologic profile and treatment outcomes of non-sensitizing EGFR and HER2 (ERBB2) activating mutations in NSCLC: Results from a single-center retrospective study by Patil, Tejas, Mushtaq, Rao Rashid, Marsh, Sydney, Azelby, Christine, Pujara, Miheer, Aisner, Dara, Purcell, William T., Schenk, Erin Lynn, Bunn, Paul A., Pacheco, Jose Maria, Camidge, D. Ross, Doebele, Robert Charles

“…Abstract only 9090 Background: The clinicopathologic characteristics and optimal treatment strategies for non-sensitizing EGFR ( ns- EGFR) and HER2 activating…”
Get full text

Identification of novel fumarate hydratase gene alterations in prostate cancer by Millis, Sherri Z., Marsh, Sydney, Pecci, Cristina, Boddupalli, Sai-Sridhar, Ross, Jeffrey S., Stephens, Phil, Miller, Vincent A., Ali, Siraj Mahamed, Wang, Jue

“…Abstract only 11585 Background: Fumarate hydratase (FH), an enzyme involved in the Krebs cycle, plays a crucial role in the generation of energy and…”
Get full text

Lysophosphatidic Acid Regulates uPAR Expression and Localization by Ciota, Alexandra M, Kobliska, Amy, Marsh, Sydney, Ellerbroek, Shawn M

“…Abstract only Lysophosphatidic acid (LPA) stimulates in vitro invasion of ovarian epithelial cancer cells through a uPA‐dependent process. We therefore…”
Get full text

Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells by Lizalek, Jason, McKenna, Tim, Huegel, Kyle, Marsh, Sydney, Carolan, Alexandra, Kobliska, Amy, Heying, Emily, Gardner, Nicole, Miller, Geoff, Kotecki, Aaron, Henningsen, Meghan, Lundt, Anastasia, Farley, Janean, Ellerbroek, Shawn M

“…Lysophosphatidic acid (LPA) is a bioactive lipid positively linked with ovarian cancer progression. The multi-functional urokinase receptor (uPAR), a…”
Get full text

The Elements of Physics. Fourth edition by Marsh, Sydney

Get full text

Laboratory Manual in Physics. Second Edition by Marsh, Sydney

Get full text

Heat for Advanced Students by Marsh, Sydney

Get full text

A Class Book of Magnetism and Electricity by Marsh, Sydney

Get full text

Hydrostatics by Marsh, Sydney

Get full text

Westpac confident on offer for rival by Virginia Marsh in Sydney

Get full text